FULGENT THERAPEUTICS LLC
The Senior Director - Cytogenetics is responsible for the review and sign-out of cytogenetic and fluorescent in-situ hybridization (FISH) cases, applying accepted criteria to formulate diagnostic and prognostic information for various specimens. This role involves collaboration with pathologists to provide appropriate interpretations, ensuring reports meet CAP guidelines, and providing clinical laboratory consultation. The position also includes participation in quality assurance measures, training personnel, and offering on-call services as needed.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for FULGENT THERAPEUTICS LLC.
FULGENT THERAPEUTICS LLC didn’t post a salary, so this is our estimate from similar listings.